AI assistant
Oncology Institute, Inc. — Director's Dealing 2024
May 24, 2024
33304_dirs_2024-05-23_57733808-eb59-4eeb-a393-feaa86d92354.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Oncology Institute, Inc. (TOI)
CIK: 0001799191
Period of Report: 2024-05-21
Reporting Person: Shah Mihir (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-21 | Common Stock | A | 151459 | $0.0 | Acquired | 474931 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-21 | Non-Qualified Stock Option (right to buy) | $2.0 | A | 378648 | Acquired | 2034-05-21 | Common Stock (378648) | Direct |
Footnotes
F1: Represents RSUs with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
F2: Amount includes a reduction of 4,650 shares from the prior filing, as it corrects an inadvertent overstatement of holdings due to clerical error.
F3: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.